BillionToOne, Inc.

NASDAQ:BLLN

Medical - Diagnostics & Research

Healthcare
$91.54 +0.84%

+$0.84 today

Market cap
$4.37B
Beta
0.90
P/E (TTM)
182.6
EPS (TTM)
$0.55
52W Low $61.96High $138.70

Volume 1.44M

Average 0.59M

BLLN Retained Earnings

Cumulative profits kept in the business rather than paid out as dividends.

BillionToOne, Inc.NASDAQ: BLLN

Retained Earnings · Q2 FY2026 · quarter ended Jun 2026

Retained earnings remains negative

Q2 FY2026 retained earnings was -$248.72M, compared with -$286.44M a year earlier.

Context

  • Retained earnings amounted to 34.1% of total assets at the end of Q2 FY2026, down 57.5 pp from a year earlier.
  • Retained earnings grew in size in 1 of the last 2 fiscal years.

What to watch

Whether retained earnings keeps rising in the next quarterly balance sheet after a +13.2% change from a year earlier.

Sources:Balance SheetText generated from reported figures; not investment advice.

Latest quarterJun 2026
-$248.72M+3.1% QoQ
Last fiscal yearDec 2025
-$274.75M+2.6% YoY
Year agoJun 2025
-$286.44M+13.2% since
Retained Earnings past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+13.2%——
1 year+2.6%——
3-year CAGR———
5-year CAGR——
10-year CAGR——

Retained Earnings history

USD · from the balance sheet

Latest · FY2025
(274.75M) USD
Year-over-year change
+2.6%

Retained Earnings vs competitors

How BLLN compares with its peers on the latest reported figures

  • BLLN's Jun 2026 retained earnings of -$248.72M is the 2nd highest of the 9 companies compared; the peer median is -$1.31B.
  • Its year-over-year change of +13.2% is the 2nd highest of 9, against a peer median of -10.3%.
  • Retained earnings amounts to 34.1% of total assets for BLLN, versus a peer median of 140.9%.
BLLN Competitors Peer median
Retained Earnings for BLLN and competitors
Company Period Latest balance YoY 3-year CAGR% of assets
FLGTFulgent Genetics, Inc.Mar 2026$505.13M -12.7%-12.9%43.7%
BLLNBillionToOne, Inc.Jun 2026-$248.72M +13.2%—34.1%
VCYTVeracyte, Inc.Jun 2026-$323.43M +26.1%—21.8%
NEONeoGenomics, Inc.Jun 2026-$448.67M -13.1%—33.2%
MYGNMyriad Genetics, Inc.Mar 2026-$1.16B -52.8%—171.7%
WGSGeneDx Holdings Corp.Jun 2026-$1.45B -7.9%—302.1%
NTRANatera, Inc.Jun 2026-$2.93B -7.0%—110.2%
GHGuardant Health, Inc.Sep 2026-$3.35B -16.9%—177.7%
GRALGRAIL, Inc.Jun 2026-$10.42B -3.9%—366.3%
Peer median (excluding BLLN) -$1.31B-10.3%-12.9%140.9%

Competitors are the stored peer set for BLLN. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Balance Sheet

USD
Metric
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents97.27M191.48M495.98M
Short-term Investments000
Net Receivables9.09M24.71M41.62M
Inventory7.2M8.73M17.55M
Other Current Assets1.94M2.9M5.42M
Total Current Assets115.5M227.82M560.56M
Property, Plant & Equipment (Net)73.87M68.85M67.1M
Goodwill000
Intangible Assets000
Long-term Investments000
Tax Assets000
Other Non-current Assets2.31M5.39M4.99M
Total Non-current Assets76.18M74.24M72.1M
Total Assets191.68M302.06M632.65M
Account Payables3.21M4.3M7.18M
Short-term Debt53.75M6.22M5.6M
Tax Payables000
Deferred Revenue3.02M2.81M2.19M
Other Current Liabilities4.26M6.64M20.44M
Total Current Liabilities66.8M28.39M47.96M
Long-term Debt35M51.48M57.23M
Deferred Tax Liabilities000
Deferred Revenue (Non-current)001.29M
Other Non-current Liabilities1.8M2.76M0
Total Non-current Liabilities94.4M105.92M104.59M
Total Liabilities161.2M134.31M152.55M
Common Stock000
Retained Earnings(240.63M)(282.2M)(274.75M)
Accumulated OCI000
Other Stockholders Equity00(1.79M)
Minority Interest000
Total Equity30.47M167.75M480.11M
Total Debt146.35M109.38M108.9M
Net Debt49.08M(82.1M)(387.08M)

BillionToOne, Inc.

NASDAQ:BLLN

Intrinsic Alpha fair value

Locked

Current Price

$91.54

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.